» Articles » PMID: 38961143

Identification of Hub Genes Associated with Diabetic Cardiomyopathy Using Integrated Bioinformatics Analysis

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jul 3
PMID 38961143
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic cardiomyopathy (DCM) is a common cardiovascular complication of diabetes, which may threaten the quality of life and shorten life expectancy in the diabetic population. However, the molecular mechanisms underlying the diabetes cardiomyopathy are not fully elucidated. We analyzed two datasets from Gene Expression Omnibus (GEO). Differentially expressed and weighted gene correlation network analysis (WGCNA) was used to screen key genes and molecules. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, and protein-protein interaction (PPI) network analysis were constructed to identify hub genes. The diagnostic value of the hub gene was evaluated using the receiver operating characteristic (ROC). Quantitative real-time PCR (RT-qPCR) was used to validate the hub genes. A total of 13 differentially co-expressed modules were selected by WGCNA and differential expression analysis. KEGG and GO analysis showed these DEGs were mainly enriched in lipid metabolism and myocardial hypertrophy pathway, cytomembrane, and mitochondrion. As a result, six genes were identified as hub genes. Finally, five genes (Pdk4, Lipe, Serpine1, Igf1r, and Bcl2l1) were found significantly changed in both the validation dataset and experimental mice with DCM. In conclusion, the present study identified five genes that may help provide novel targets for diagnosing and treating DCM.

Citing Articles

Murine Model Insights: Identifying Dusp15 as a Novel Biomarker for Diabetic Cardiomyopathy Uncovered Through Integrated Omics Analysis and Experimental Validation.

Zhu L, Dong Y, Guo H, Qiu J, Guo J, Hu Y Diabetes Metab Syndr Obes. 2025; 18:515-527.

PMID: 39990179 PMC: 11847420. DOI: 10.2147/DMSO.S501563.


Generalizability of machine learning models for diabetes detection a study with nordic islet transplant and PIMA datasets.

Chellappan D, Rajaguru H Sci Rep. 2025; 15(1):4479.

PMID: 39915538 PMC: 11802925. DOI: 10.1038/s41598-025-87471-0.

References
1.
Holness M, Bulmer K, Gibbons G, Sugden M . Up-regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) protein expression in oxidative skeletal muscle does not require the obligatory participation of peroxisome-proliferator-activated receptor alpha (PPARalpha). Biochem J. 2002; 366(Pt 3):839-46. PMC: 1222844. DOI: 10.1042/BJ20020754. View

2.
El Hayek M, Ernande L, Benitah J, Gomez A, Pereira L . The role of hyperglycaemia in the development of diabetic cardiomyopathy. Arch Cardiovasc Dis. 2021; 114(11):748-760. DOI: 10.1016/j.acvd.2021.08.004. View

3.
Li Z, Liu J, Wang W, Zhao Y, Yang D, Geng X . Investigation of hub genes involved in diabetic nephropathy using biological informatics methods. Ann Transl Med. 2020; 8(17):1087. PMC: 7575993. DOI: 10.21037/atm-20-5647. View

4.
Olaniyi K, Olatunji L . Oral ethinylestradiol-levonorgestrel attenuates cardiac glycogen and triglyceride accumulation in high fructose female rats by suppressing pyruvate dehydrogenase kinase-4. Naunyn Schmiedebergs Arch Pharmacol. 2018; 392(1):89-101. DOI: 10.1007/s00210-018-1568-3. View

5.
Ullrich A, Gray A, Tam A, Tsubokawa M, Collins C, Henzel W . Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986; 5(10):2503-12. PMC: 1167146. DOI: 10.1002/j.1460-2075.1986.tb04528.x. View